Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched ...

Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...

By Maggie Fick, Mrinalika Roy and Sabrina Valle SAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

A low-carbohydrate diet combined with resistance training achieves notable weight loss even in individuals with a high ...

Wegovy pill, the first ever non-injectable GLP-1 for obesity, from drugmaker Novo Nordisk. Competitors like Eli Lilly are ...

President Trump has talked in the past about people he knows who have taken “the fat drug.” President Trump has often mused ...

The performance of asthma severity scores, in terms of reliability and responsiveness, differs between children with obesity ...

Eli Lilly and Nimbus Therapeutics have entered into a multi-year collaboration and exclusive licensing agreement to develop ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 ...

CenterWell Pharmacy announced that it will dispense Eli Lilly's obesity drugs within employer weight management programs. | ...

Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...